O crescent arsenal terapêutico na esclerose múltipla (EM) tem permitido tratamentos mais efetivos e personalizados, mas a escolha e o manejo das terapias modificadoras da doença (TMDs) tem se tornado cada vez mais complexos. Neste contexto, especialistas do Comitê Brasileiro de Tratamento e Pesquisa em Esclerose Múltipla e do Departamento Científico de Neuroimunologia da Academia Brasileira de Neurologia reunir...
Made available in DSpace on 2018-11-26T22:40:49Z (GMT). No. of bitstreams: 0 Previous issue date: 2018-08-01. Added 1 bitstream(s) on 2019-10-09T18:27:56Z : No. of bitstreams: 1 S0004-282X2018000800539.pdf: 336862 bytes, checksum: 861f2018734ed5dc938f69878cf50b6e (MD5); Biogen Idec; Genzyme; Merck; Novartis; Rocha; Teva; Roche; Sanofi-Genzyme; World Federation of Neurology; European Committee on Treatment and R...
OBJECTIVES: The aims of the current study were 1) to evaluate the reliability and validity of the Brazilian version of the 15-item Myasthenia Gravis Quality of Life Scale and 2) to investigate the quality of life of Brazilian patients with myasthenia gravis and its determinants. METHODS: This cross-sectional study included 69 patients with myasthenia gravis who underwent neurological evaluation and completed qu...
Submitted by Vitor Silverio Rodrigues (vitorsrodrigues@reitoria.unesp.br) on 2014-05-27T11:28:42Z No. of bitstreams: 0Bitstream added on 2014-05-27T14:32:22Z : No. of bitstreams: 1 2-s2.0-84875195830.pdf: 324522 bytes, checksum: 267b0650456f6d415bbc8ed2ec7e9c57 (MD5); Made available in DSpace on 2014-05-27T11:28:42Z (GMT). No. of bitstreams: 0 Previous issue date: 2013-03-20; Background: Neuromyelitis optica (N...